The Efficacy And Safety Of Risperidone In The Treatment Of Adolescents With Schizophrenia: A Six-Month Open-Label Study
Phase of Trial: Phase III
Latest Information Update: 30 Mar 2010
At a glance
- Drugs Risperidone (Primary)
- Indications Schizophrenia
- Focus Adverse reactions; Therapeutic Use
- Sponsors Janssen Research & Development
- 30 Mar 2010 Actual patient number (381) added as reported by ClinicalTrials.gov.
- 30 Mar 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 30 Mar 2010 Actual end date (Dec 2006) added as reported by ClinicalTrials.gov.